<div><span style="font-size: medium;">Jonathan M. Rothberg (born 1963) is an American scientist and entrepreneur.</span></div>
<div> </div>
<div>Early life</div>
<div> </div>
<div>Jonathan was born in New Haven, Connecticut the son of Lillian and Dr. Henry Rothberg a chemical engineer. Prior to Jonathan's birth, Lillian and Dr. Henry Rothberg founded Laticrete International, Inc. a family-owned, global manufacturer of products for the installation of tile and stone. Jonathan's family established the foundation for his scientific career; early on, he was heavily influenced by his father's engineering background and problem solving abilities, as well as his mother's belief that he would "do good science."[1]</div>
<div> </div>
<div> </div><div><span style="font-size: large;">Education and scientific career</span></div>
<div> </div>
<div>INSTITUTION AND LOCATION</div>
<div>1985</div>
<div> </div>
<div><span style="font-size: large;">Chemical Engineering – option in Biomedical Engineering</span></div>
<div> </div>
<div>Rothberg earned a B.S. in Chemical Engineering with an option in Biomedical Engineering from Carnegie Mellon University, Pittsburgh, PA in 1985. After completing college at Carnegie Mellon, Jonathan went on to attend Yale University and earn a M.S., M.Phil., and Ph.D. in biology. His thesis at Yale focused on decoding a gene called slit responsible for wiring the nervous system. Jonathan's thesis work resulted in publication of a cover article in the journal Cell in 1988. ↵While a graduate student at Yale Jonathan founded CuraGen, one of the first genomics companies (CellDex Therapeutics acquired CuraGen in fall of 2009).[2] At CuraGen, Jonathan and his team focused on how the proteins encoded in a genome function together, and published the first global proteomic maps of a eukaryotic cell and a metazoan organism (featured on the covers of Nature and Science) and developed drugs for the treatment of metastatic skin and breast cancer.</div>
<div>Rothberg is a member of the National Academy of Engineering, the Connecticut Academy of Medical Science and Engineering, and is a life of trustees of Carnegie Mellon University.</div>
<div> </div>
<div><span style="font-size: large;">Positions and honors</span></div>
<div> </div>
<div><span style="font-size: large;">Positions</span></div>
<div>2007–2013 Founder, CEO and Chairman of the Board, Ion Torrent, Inc., Guilford, CT</div>
<div>2005–Present Board of Trustees, Carnegie Mellon University, Pittsburgh, PA</div>